Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
41 Cards in this Set
- Front
- Back
What is indicative of a positive PPD test?
|
Induration of the tissue mediated by a type IV delayed hypersensitivity reaction
|
|
What is the IFN-gamma test to diagnose TB?
|
Test quantifies the synthesis of IFN-gamma by sensitized T-cells in response to challenge with PPD
|
|
Does a positive PPD mean the patient has latent TB?
|
No, it just means that the patient has TB --> test does not differentiate latent from active disease
|
|
What is the MOA of Isoniazid?
|
INH is a prodrug which is converted to its active form by the mycobacterial catalase-peroixdase
Active INH prevents the synthesis of Mycolic acid (component of mycobacterium cell wall) |
|
How does the active INH metabolite prevent the synthesis of mycolic aicd?
|
Binds covalently to the acyl carrier protein and the b-ketoacyl carrier protein synthetase
|
|
INH is ______________ for latent (non-dividing) Mycobacterium, but it kills bacilli which are dividing rapidly
|
Bacteriostatic
|
|
Why is INH NEVER used as a single agent in the treatment of ACTIVE TB?
|
Rapid development of bacterial resistance
|
|
In healthy patients with a positive PPD, how many months of Isoniazid treatment is required?
|
9 months
|
|
Can INH be used as a single agent to treat patients who have a positive PPD and a negative chest X-ray?
|
Yes
|
|
What percent of patients with a positive PPD and a negative CXR that don't receive INH will develop tubercular disease at some time in their life?
|
5-15%
|
|
INH for 9 months reduces the probability of PPD+ converters from developing active disease by ______
|
50%
|
|
INH is metabolized by hepatic ______________ and _______ acetylators are thought to be at increased risk for hepato- and neurotoxicity?
|
N-acetylation
Slow |
|
Should a patient discontinue INH if they exhibit a 3-4X increase in ALT and AST?
|
No
|
|
What drug should be used if a patient is 35+ y.o. & the date of seroconversion (TB) is unknown?
|
Rifampin
|
|
Intake of ___________ increases hepatotoxicity caused by INH?
|
ChaCho's margaritas
|
|
INH antagonizes the enzymatic reactions which use ____________ as a cofactor?
|
Pyridoxine (vitamin B6)
|
|
What is the effect of INH antagonism of the reactions that use Pyridoxine as a co-factor?
How is this condition treated? |
Peripheral neuropathy
Daily dose of Vitamin B6 prevents and reverses this neuropathy |
|
What kind of patients do you give B6 to that are taking INH b/c of a positive PPD and negative CXR?
|
Patients predisposed to neuropathy:
-pregnant women, patients w/ diabetes mellitus, uremia, malnutrition, HIV or seizures |
|
What is the MOA of Rifampin and Rifabutin?
|
Inhibit mRNA synthesis by binding to the beta-subunit of the bacterial DNA-dependent-RNA polymerase
*drugs do not bind to human RNA pol |
|
Are Rifampin & Rifabutin bactericidal or bacteriostatic?
|
Bactericidal --> easily penetrate tissues to kill intracellular mycobacteria and bugs in abscesses
|
|
Why is Rifampin never used as a single agent in the treatment of active TB?
|
b/c of the development of bacterial resistance
|
|
Rifampin is a strong inducer of ____________ and enhances the clearance of drugs used to treat _____ infections
|
CYP450
HIV *protease inhibitors and NNRTIs |
|
What drug is used in HIV + patients with TB due to a 50% reduction of CYP induction compared to Rifampin?
|
Rifabutin
|
|
Drug regimens with Rifampin clear the sputum of mycobacteria about ______ weeks faster than those w/o Rifampin
|
Two
|
|
Rifampin can be used as an alternative for INH prophylaxis of TB. How long is treatment required for?
|
Four months
|
|
What other activities does Rifampin have?
|
1. Meningococci (elimination of carrier state)
2. Pneumococci (PCN resistant) 3. Staph (MRSA) |
|
What are the toxicities of Rifampin?
|
1. Urine, skin saliva, tears, and skin turn orange
2. Flu-like syndrome 3. Hepatitis w/ elevated LFT's 4. Drug-Drug interactions--increase the hepatic clearance of other drugs |
|
What pregnancy category are INH and Rifampin?
|
Catergory C
*benefits should exceed the risk to the fetus |
|
What are the S/E of Rifabutin?
|
Yellow discoloration of the skin
Polymyalgias Uveitis |
|
What is the MOA of Pyrazinamide?
|
Unknown--but kills semi-dormant, intracellular bacilli in macrophages
|
|
What is the therapeutic use of Pyrazinamide?
|
Part of the RIPE combination for active TB treatment
|
|
What % of the isolates resistant to INH-Rifampin are resistant to PZA?
|
50%
|
|
What are the toxicities of PZA?
|
N/V
Hepatotoxicity (1-5%) No drug-drug interactions |
|
What is the MOA of Ethambutol?
|
Bacteriostatic against actively growing TB bacilli via inhibition of arabinosyl transferase--an enzyme which polymerizes arabinoglycan
Arabinoglycan is a component of the mycobacterial cell wall, so ethambutol inhibits cell wall synthesis |
|
What are the therapeutic uses of Ethambutol?
|
Part of the RIPE combination for active TB treatment
|
|
What % of the isolates resistant to INH-Rifampin are resistant to Ethambutol?
|
80%
|
|
What are the toxicities associated with Ethambutol?
|
1. Ocular damage--retrobulbuar neuritis
(impaired vision abnormal red/green vision; get vision exam b4 therapy_ 2. No drug-drug interactions |
|
What is the MOA of Streptomycin?
|
Aminoglycoside drug that inhibits bacterial protein synthesis
Acts primarily against extracellular bacteria |
|
What are the Clinical uses of Streptomycin?
|
1. i.m. or i.v. to treat patients w/ mycobacterial meningitis or disseminated infection
2. 80% of isolates resistant to INH-rifampin are resistant to streptomycin 3.Sometimes replaces EMB in the INH-rifampin-PZA regimen |
|
What are the toxicities of Streptomycin?
|
Greater VESTIBULAR toxicity
(in comparison to other aminoglycosides) LESS auditory and renal toxicity |
|
What drugs are used to treat MDR TB?
|
Ciprofloxacin & Levofloxacin
Moxifloxacin shows the greatest activity against TV |